Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals
Titel:
Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals
Auteur:
Medhat, Mohammed A. El-Kassas, Mohamed Karam-Allah, Haidi Al Shafie, Ahmed Abd-Elsalam, Sherief Moustafa, Ehab Hassany, Sahar M. Salama, Marwa Abd Elghafar, Mohamed S. Sayed, Hamdy Badr, Mohamed Kamal, Dalia T. Shamseldeen, Ahmed Ossimi, Ashima'a Moaz, Inas Esmael, Hossam El-deen Ezz Eldin, Azza M. Ezzat, Sameera Abdelghaffar, Hossam Abdelghaffar, Khaled